Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.20.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following potentially dilutive securities have been excluded from the computation of diluted weighted average shares outstanding as they would be anti-dilutive:

 

    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2020     2019     2020     2019  
Options to purchase common stock     1,781,488       1,678,345       1,781,488       1,678,345  
Restricted Stock Unvested     421,253       -       421,253       -  
Series H-1, H-3, H-4, H-5, I, J, pre-merger AYRO and Merger common stock purchase warrants     1,988,175       393,477       1,988,175       393,477  
Series H, H-3, H-6, and pre-merger AYRO Seed Preferred Stock     3,272       1,495,291       3,272       1,495,291  
Totals     4,194,188       3,567,113       4,194,188       3,567,113